Treatments

Drugmakers set to raise U.S. prices on at least 500 drugs in January--analysis

Fri, 2023-12-29 07:48 — mike kraft

Exclusive: Drugmakers set to raise U.S. prices on at least 500 drugs in January Drugmakers including Pfizer , Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January. Michael Erman,Patrick Wingrove Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Drugmakers set to raise U.S. prices on at least 500 drugs in January--analysis
Log in or register to post comments

A group of Minnesotans are suing local hospitals after loved ones died from COVID-19

Thu, 2023-12-28 15:19 — mike kraft

A group of Minnesotans are suing local hospitals after losing loved ones to COVID-19 A group of Minnesotans gather together to share stories about COVID-19 and the loved ones they lost. CBS Minnesota

...

The group believes doctors received bonuses and incentives for giving medications, like remdesivir, to sick family members. They claim their loved ones got worse after receiving the medication....

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about A group of Minnesotans are suing local hospitals after loved ones died from COVID-19
Log in or register to post comments

Use of Covid antiviral medicineby infected Americans remains low --study

Thu, 2023-12-28 15:10 — mike kraft

COVID antiviral uptake low among eligible Americans Over the course of the study, most participants were eligible for antiviral use. CIDRAP

A new report published in Open Forum Infectious Diseases demonstrates that, despite the proven effectiveness of Paxlovid and molnupiravir against severe COVID-19 outcomes, uptake of these two antivirals remains low among Americans with COVID.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Use of Covid antiviral medicineby infected Americans remains low --study
Log in or register to post comments

No consistent link found between antiviral drugs like Paxlovid and COVID rebound --U.S.G. reviews

Fri, 2023-12-22 07:34 — mike kraft

Reviews uncover no consistent link between antiviral drugs like Paxlovid and COVID rebound Igor Vershinsky / iStock CIDRAP

Two systematic reviews by US federal agencies on the possible link between antiviral treatment for COVID-19 and viral rebound—one specifically on Paxlovid—find no consistent association. The studies were published yesteray in Morbidity and Mortality Weekly Report.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about No consistent link found between antiviral drugs like Paxlovid and COVID rebound --U.S.G. reviews
Log in or register to post comments

Long- COVID : UK primary care costs nearly 45% higher among long-COVID patients--study

Wed, 2023-11-22 09:10 — mike kraft

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Long- COVID : UK primary care costs nearly 45% higher among long-COVID patients--study
Log in or register to post comments

Federal COVID aid helped boost telehealth expansion in rural America

Fri, 2023-11-17 09:31 — mike kraft

COVID aid fuels telehealth expansion in rural America - Roll Call As rural hospitals deal with workforce shortages and declining populations, some say telehealth offers a chance to bridge the gap. Lauren Clason Roll Call

...

Federal pandemic aid also helped slow the rate of rural hospital closures. But as facilities contend with lingering inflation, workforce shortages and declining populations, the pace of those closures is picking up again.

Telehealth offers a chance to bridge the gap in hospital deserts.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Federal COVID aid helped boost telehealth expansion in rural America
Log in or register to post comments

Small preliminary study suggests Covid rebound is far more common with Paxlovid than without

Tue, 2023-11-14 07:46 — mike kraft

Study suggests Covid rebound is far more common with Paxlovid than without A small and preliminary study published Monday seems to indicate that patients receiving Paxlovid are far more likely to experience Covid rebound than those who did not take it. Matthew Herper STAT

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Small preliminary study suggests Covid rebound is far more common with Paxlovid than without
Log in or register to post comments

AstraZeneca says it prioritizes US for RSV drug amid surge in cases

Mon, 2023-11-13 08:33 — mike kraft

AstraZeneca prioritizes US for RSV drug amid surge in cases AstraZeneca on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was approved in July to prevent the disease in infants and toddlers, as a surge of cases is outpacing supply. Patrick Wingrove,Maggie Fick Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca says it prioritizes US for RSV drug amid surge in cases
Log in or register to post comments

Opinion: Covid-19 is still around, and so are these misconceptions--Dr. Tom Frieden

Thu, 2023-11-09 07:05 — mike kraft

Dr. Tom Frieden: Covid-19 is still around, and so are these misconceptions Covid-19 hasn’t gone away, and it won’t any time soon. It’s now part of the landscape of health threats. Although the coronavirus continues to kill and cause lasting damage, our immunity, vaccines and treatments have tamed the pandemic. Opinion by Dr. Tom Frieden AOL

...

Three widely held misconceptions reflect and contribute to polarization. For each, there’s a kernel of truth that appears to support the misconception, but the reality is clear.

...

Country / Region Tags:

General Topic Tags: